Digging with the CEO Into Balfour Beatty's Results

Bloomberg's Mark Barton discusses Balfour Beatty's latest results with the company's Chief Executive Officer Ian Tyler.

Will Acquiring Allergan Impact Pfizer's R&D?
45:46 - Dr. Beth Seidenberg, Kleiner Perkins Caufield & Byers general partner, discusses the financial implications of the Pfizer-Allergan deal. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • How to Manage the Hype in Tech Startups
  • Yuan Addition to SDR to Draw Inflows to China: Pihlman
  • U.S. Markets: What Caused Today's Weakness?